Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia

Leukemia. 2005 Sep;19(9):1689-92. doi: 10.1038/sj.leu.2403874.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Benzamides
  • Drug Therapy, Combination
  • Female
  • Humans
  • Imatinib Mesylate
  • Interferons / adverse effects
  • Interferons / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced*
  • Neoplasms, Second Primary / diagnosis
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Interferons